CRISPR/Cas9-Mediated Genome Editing in Epstein-Barr Virus-Transformed Lymphoblastoid B-Cell Lines (Q47482061)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 January 2018

CRISPR/Cas9-Mediated Genome Editing in Epstein-Barr Virus-Transformed Lymphoblastoid B-Cell Lines.

Language	Label	Description	Also known as
English	CRISPR/Cas9-Mediated Genome Editing in Epstein-Barr Virus-Transformed Lymphoblastoid B-Cell Lines	scientific article published on 16 January 2018	CRISPR/Cas9-Mediated Genome Editing in Epstein-Barr Virus-Transformed Lymphoblastoid B-Cell Lines.

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 February 2018

http://europepmc.org/abstract/MED/29337376

CRISPR/Cas9-Mediated Genome Editing in Epstein-Barr Virus-Transformed Lymphoblastoid B-Cell Lines (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 February 2018

http://europepmc.org/abstract/MED/29337376

0 references

0 references

Epstein–Barr virus

1 reference

based on heuristic

inferred from title

CRISPR-Cas method

1 reference

based on heuristic

inferred from title

object named as

Sizun Jiang

1

0 references

author name string

Liang Wei Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

3 February 2018

http://europepmc.org/abstract/MED/29337376

Michael J. Walsh

3

0 references

Stephen J. Trudeau

4

0 references

Catherine Gerdt

5

1 reference

Europe PubMed Central

PubMed publication ID

3 February 2018

http://europepmc.org/abstract/MED/29337376

Bo Zhao

6

1 reference

Europe PubMed Central

PubMed publication ID

3 February 2018

http://europepmc.org/abstract/MED/29337376

Benjamin E. Gewurz

7

0 references

Michael J Walsh

3

1 reference

Europe PubMed Central

PubMed publication ID

3 February 2018

http://europepmc.org/abstract/MED/29337376

Stephen J Trudeau

4

1 reference

Europe PubMed Central

PubMed publication ID

3 February 2018

http://europepmc.org/abstract/MED/29337376

Benjamin E Gewurz

7

1 reference

Europe PubMed Central

PubMed publication ID

3 February 2018

http://europepmc.org/abstract/MED/29337376

publication date

16 January 2018

1 reference

Europe PubMed Central

PubMed publication ID

3 February 2018

http://europepmc.org/abstract/MED/29337376

Current Protocols in Molecular Biology

0 references

Current protocols in molecular biology

1 reference

Europe PubMed Central

PubMed publication ID

3 February 2018

http://europepmc.org/abstract/MED/29337376

121

1 reference

Europe PubMed Central

PubMed publication ID

3 February 2018

http://europepmc.org/abstract/MED/29337376

31.12.1-31.12.23

1 reference

Europe PubMed Central

PubMed publication ID

3 February 2018

http://europepmc.org/abstract/MED/29337376

A decade of discovery: CRISPR functions and applications

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

Easy quantitative assessment of genome editing by sequence trace decomposition

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

Characterization of genomic deletion efficiency mediated by clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cells

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

Genetic analysis of human traits in vitro: drug response and gene expression in lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

Multiplex genome engineering using CRISPR/Cas systems

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

A tiling-deletion-based genetic screen for cis-regulatory element identification in mammalian cells

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation.

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

CRISPR-Cas: biology, mechanisms and relevance

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

Development and applications of CRISPR-Cas9 for genome engineering

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

The International HapMap Project

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9.

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

RNA-guided human genome engineering via Cas9

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

The EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growth

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

Selective transformation of B lymphocytes by E.B. virus

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

A CRISPR toolbox to study virus-host interactions

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

CRISPR-Cas systems for editing, regulating and targeting genomes

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

A global reference for human genetic variation

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

Rapid and efficient one-step generation of paired gRNA CRISPR-Cas9 libraries

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

Biology and Applications of CRISPR Systems: Harnessing Nature's Toolbox for Genome Engineering

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

21 January 2018

Immunoblotting and Immunodetection

1 reference

https://api.crossref.org/works/10.1002%2FCPMB.51

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CPMB.51

1 reference

Europe PubMed Central

PubMed publication ID

3 February 2018

http://europepmc.org/abstract/MED/29337376

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 February 2018

http://europepmc.org/abstract/MED/29337376

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47482061&oldid=2238680879"